Determining the best global supply strategy based upon the study design can be a complex discussion involving a number of variables depending upon the study design.
With high access to patient pools, speedy patient recruitment and lower in-country costs, Eastern Europe continues to be a popular target for sponsors when running clinical trials.
Many of our sponsor companies have not had previous experience of European Union requirements for clinical trials or commercial products.
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients